High materiality7/10
BioCryst Pharma (BCRX) PT Raised to $17 at Jefferies
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies raises BCRX price target to $17; current price around $9.55.
- Jefferies raises PT to $17; price $9.55.
Key facts
- 01
Target: $17
- 02
Posted price: $9.55
- 03
Analyst firm: Jefferies
- 04
Analyst: Maury Raycroft
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.